Techulon Inc. Email Format
Biotechnology ResearchVirginia, United States2-10 Employees
Techulon Inc. is a biotechnology company focused on developing treatments for infections that defy standard therapies. Its approach targets bacteria at the genomic level, aiming for potent medicines with reduced risk of resistance compared with conventional antibiotics. The company relies on a system that enables nucleic acid delivery across various therapeutic applications and uses informatics to identify new bacterial gene targets for antimicrobial development. In this way, Techulon occupies a niche at the intersection of genomic medicine and antimicrobial research. Headquartered in Blacksburg, Virginia, the company operates with a small team. It has been awarded a contract by DARPA to advance its antimicrobial platform toward addressing both Gram-negative and Gram-positive bacteria.